Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
JoAnn V. Pinkerton(Unknown), Lineke Zuurman(Bayer (Switzerland)), Cláudio N. Soares(Unknown), Nick Panay(Queen Charlotte's and Chelsea Hospital), Rebecca C. Thurston(University of Pittsburgh), Susanne Parke(Bayer (Germany)), Hadine Joffe(Beth Israel Deaconess Medical Center), Uwe Mellinger(Bayer (Germany)), Pauline M. Maki(University of Illinois Chicago), Ulrike Krahn(Bayer (Germany)), James A. Simon(George Washington University), Nazanin Haseli Mashhadi(Bayer (United Kingdom)), Rossella E. Nappi(University Hospital Foundation), Christian Seitz(Bayer (Germany)), Cecilia Caetano(Bayer (Switzerland)), Claudia Haberland(Bayer (Germany))
Cited by 90
Related Papers
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
|Climacteric|2016|958
Recommendations for the management of postmenopausal vaginal atrophy
|Climacteric|2010|526
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
|New England Journal of Medicine|2017|492
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
|New England Journal of Medicine|2008|469